Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Short Interest Down 39.1% in February

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) was the recipient of a large drop in short interest in February. As of February 15th, there was short interest totalling 520,300 shares, a drop of 39.1% from the January 31st total of 853,700 shares. Based on an average trading volume of 1,100,000 shares, the days-to-cover ratio is currently 0.5 days. Currently, 2.4% of the shares of the stock are short sold.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC grew its stake in shares of Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) by 142.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 36,622 shares of the company’s stock after buying an additional 21,532 shares during the period. Renaissance Technologies LLC owned 0.29% of Inspira Technologies Oxy B.H.N. worth $37,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 12.72% of the company’s stock.

Inspira Technologies Oxy B.H.N. Stock Down 3.8 %

IINN traded down $0.03 during midday trading on Monday, reaching $0.87. 170,031 shares of the company’s stock were exchanged, compared to its average volume of 1,681,875. Inspira Technologies Oxy B.H.N. has a 1-year low of $0.77 and a 1-year high of $2.45. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.13 and a current ratio of 2.23. The business’s 50-day moving average price is $0.97 and its 200 day moving average price is $1.15.

Inspira Technologies Oxy B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.